CHICAGO & LEXINGTON, Mass.-()-MC10, Inc., the company delivering wearable sensor systems for personalized health insights, and the Shirley Ryan AbilityLab, the nationally recognized rehabilitation research hospital, today announced their collaboration around novel neurodegenerative and motion related disability therapy development.

The Shirley Ryan AbilityLab will execute clinical research studies using MC10’s BioStampRC® product, a wearable sensor system designed to seamlessly capture physiological data from across the body.

“MC10’s technology has the potential to reshape rehabilitation. We look forward to developing new therapies and solutions with BioStampRC sensors, furthering our goal of improving treatment and recovery, and of advancing human ability,” stated David Zembower, Ph.D., Executive Director of Innovation and Clinical Research at the Shirley Ryan AbilityLab.

“MC10 is dedicated to improving healthcare with digital solutions. By collaborating with the Shirley Ryan AbilityLab, an institution committed to driving breakthroughs in human ability, we’re positioning our technology to make a real, positive impact in human health,” commented Scott Pomerantz, Chief Executive Officer of MC10. The Shirley Ryan AbilityLab and MC10 plan for multiple publications and conference proceedings to share outcomes from their clinical study collaboration.

About Shirley Ryan AbilityLabThe Shirley Ryan AbilityLab, formerly the Rehabilitation Institute of Chicago, is the global leader in physical medicine and rehabilitation for adults and children with the most severe, complex conditions – from traumatic brain and spinal cord injury to stroke, amputation and cancer-related impairment.

The Shirley Ryan AbilityLab expands and accelerates leadership in the field that began at RIC in 1953 – its care and research designated the “No. 1 Rehabilitation Hospital in America” by U.S. News & World Report every year since 1991.

Upon opening in March 2017, the $550 million, 1.2-million-square-foot Shirley Ryan AbilityLab became the first-ever “Translational” research hospital in which clinicians, scientists, innovators and technologists work together in the same space, surrounding patients, discovering new approaches and applying research real time.